Universal Vision Biotechnology Co., Ltd. (TPEX: 3218)

Universal Vision Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	931.21	1,063	703.02	534.19	616	372.14
Short-Term Investments	532.72	578.36	576.62	505.81	461.75	338.97
Cash & Short-Term Investments	1,464	1,641	1,280	1,040	1,078	711.11
Cash Growth	-15.20%	28.23%	23.04%	-3.50%	51.56%	-13.25%
Accounts Receivable	565.55	584.25	581.82	534.93	377.13	342.14
Other Receivables	5.44	2.17	3.37	11.31	33.8	42.86
Receivables	570.99	586.42	585.18	546.25	410.92	385
Inventory	279.69	294.52	227.62	115.65	62.62	61.02
Other Current Assets	65.33	58.03	66.54	77.21	90.78	63.51
Total Current Assets	2,380	2,580	2,159	1,779	1,642	1,221
Property, Plant & Equipment	2,401	2,323	2,206	1,724	1,413	1,312
Long-Term Investments	31.61	-	-	-	-	-
Other Intangible Assets	22.24	22.98	25.91	26.57	26.52	7.25
Long-Term Deferred Tax Assets	68.26	67.25	55.91	48.31	34.47	44.59
Other Long-Term Assets	132.83	137.06	59.25	171.76	53.11	62.43
Total Assets	5,036	5,131	4,506	3,750	3,169	2,647
Accounts Payable	248.35	312.31	254.55	210.5	122.93	76.48
Accrued Expenses	192.2	226.54	210.26	170.08	128.1	78.97
Short-Term Debt	15.42	8.67	-	-	176.9	80.95
Current Portion of Long-Term Debt	-	1.3	9.17	9.03	-	-
Current Portion of Leases	174.25	155.27	141.45	130.72	108	110.22
Current Income Taxes Payable	165.87	162.57	134.37	85.7	77.44	46.16
Current Unearned Revenue	28.82	24.19	23.32	16.24	14.22	8.57
Other Current Liabilities	115.83	132.25	137.25	109.39	125.83	124.37
Total Current Liabilities	940.74	1,023	910.38	731.66	753.41	525.7
Long-Term Debt	-	-	1.32	10.33	-	-
Long-Term Leases	676.36	613.02	631.7	617.45	329.24	391.58
Long-Term Deferred Tax Liabilities	60.96	58.39	44.26	24.94	-	-
Other Long-Term Liabilities	77.13	93.12	88.8	36.78	47.04	34.55
Total Liabilities	1,755	1,788	1,676	1,421	1,130	951.83
Common Stock	847.25	847.25	799.29	761.23	761.23	761.23
Additional Paid-In Capital	381.92	381.92	381.92	381.92	381.92	381.92
Retained Earnings	1,906	1,960	1,488	1,056	779.86	462.29
Comprensive Income & Other	6.91	-11.38	-5.04	-10.37	-9.12	-14.09
Total Common Equity	3,142	3,178	2,664	2,188	1,914	1,591
Minority Interest	139.31	165.33	165.02	140.13	125.55	103.99
Shareholders' Equity	3,281	3,343	2,829	2,328	2,039	1,695
Total Liabilities & Equity	5,036	5,131	4,506	3,750	3,169	2,647
Total Debt	866.02	778.26	783.65	767.53	614.14	582.74
Net Cash (Debt)	597.91	862.65	495.99	272.47	463.61	128.37
Net Cash Growth	-34.97%	73.92%	82.03%	-41.23%	261.16%	-80.75%
Net Cash Per Share	7.04	10.16	5.85	3.21	5.46	1.51
Filing Date Shares Outstanding	84.73	84.73	84.72	84.72	84.72	84.72
Total Common Shares Outstanding	84.73	84.73	84.72	84.72	84.72	84.72
Working Capital	1,439	1,557	1,249	1,047	888.66	694.93
Book Value Per Share	37.08	37.51	31.45	25.83	22.59	18.78
Tangible Book Value	3,119	3,155	2,638	2,162	1,887	1,584
Tangible Book Value Per Share	36.82	37.23	31.14	25.52	22.28	18.70
Land	179.87	179.87	179.87	179.87	179.87	179.87
Buildings	67.11	67.11	66.76	66.76	66.65	66.54
Machinery	2,270	2,165	1,884	1,480	1,346	1,112
Construction In Progress	21.81	32.82	91.84	-	-	-
Leasehold Improvements	661.18	615.67	473.07	340.85	306.52	260.67

Source: S&P Capital IQ. Standard template. Financial Sources.